ICI GRENADE SHEEP DIP

Main information

  • Trade name:
  • ICI GRENADE SHEEP DIP
  • Class:
  • AgChem
  • Medicine domain:
  • Plants
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • ICI GRENADE SHEEP DIP
    Australia
  • Language:
  • English

Therapeutic information

  • Therapeutic group:
  • GOAT | SHEEP | BILLY | BUCK | CAPRA HIRCUS | DOE | EWE | HOGGET | KID | LAMB | OVINE | RAM | WEANER | WETHER
  • Therapeutic area:
  • STOCK PESTICIDE
  • Therapeutic indications:
  • KED | LOUSE | SHEEP BODY LOUSE | DAMALINIA OVIS (PREV. GENUS) | LICE - SYNTHETIC PYRETHROID RE | SHEEP BODY LICE

Other information

Status

  • Source:
  • Australian Pesticides and Veterinary Medicines Authority (APVMA)
  • Authorization status:
  • Archived
  • Authorization number:
  • 33466
  • Last update:
  • 09-08-2016

There are no safety alerts related to this product.

11-12-2018


Felodipine / ramipril: List of nationally authorised medicinal products - PSUSA/00001358/201803

Felodipine / ramipril: List of nationally authorised medicinal products - PSUSA/00001358/201803

Felodipine / ramipril: List of nationally authorised medicinal products - PSUSA/00001358/201803

Europe - EMA - European Medicines Agency

26-11-2018

Nyxoid (Mundipharma Corporation (Ireland) Limited)

Nyxoid (Mundipharma Corporation (Ireland) Limited)

Nyxoid (Active substance: naloxone) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)7966 of Mon, 26 Nov 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/4325/T/04

Europe -DG Health and Food Safety

11-6-2018

Harvoni (Gilead Sciences Ireland UC)

Harvoni (Gilead Sciences Ireland UC)

Harvoni (Active substance: ledipasvir/sofosbuvir) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)3759 of Mon, 11 Jun 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/3850/T/67

Europe -DG Health and Food Safety

16-5-2018

EU/3/14/1382 (Novartis Europharm Limited)

EU/3/14/1382 (Novartis Europharm Limited)

EU/3/14/1382 (Active substance: Allogeneic CD34+ cells expanded ex vivo with an aryl hydrocarbon receptor antagonist) - Transfer of orphan designation - Commission Decision (2018)3044 of Wed, 16 May 2018 European Medicines Agency (EMA) procedure number: EMA/OD/120/14/T/01

Europe -DG Health and Food Safety